Related Experiment Videos

Chiral LC of a cholesterol-lowering drug using serum albumin mobile phases

J E Noroski¹, D J Mayo

¹Bristol-Myers Squibb Pharmaceutical Research Institute, New Brunswick, NJ 08903-0191, USA.

Journal of Pharmaceutical and Biomedical Analysis

|January 1, 1995

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Daily catheter-directed single dosing of t-PA in treatment of acute deep venous thrombosis of the lower extremity.

Journal of vascular and interventional radiology : JVIR·2001

Serologic evidence of heparin sensitization in cancer patients receiving heparin flushes of venous access devices.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·1999

Heparin-induced thrombocytopenia (HIT) due to heparin flushes: a report of three cases.

Journal of internal medicine·1999

Fibrin sheath formation and chemotherapy extravasation: a case report.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·1998

Low-dose urokinase infusions to treat fibrinous obstruction of venous access devices in cancer patients.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1997

Superior vena cava thrombosis associated with a central venous access device: a case report.

Clinical journal of oncology nursing·1997

See all related articles